ASTM E3011-22 PDF

Overview

ASTM E3011-22: Standard Practice for In vitro Production of Clostridioides difficile Spores provides a precise methodology for the propagation of C. difficile spores using liver broth. Developed by ASTM International for laboratories and research facilities, this standard is highly relevant for studies requiring reliable, high-titer, and pure spore preparations. The standard addresses both procedural requirements and critical safety considerations, ensuring consistency and safety in antimicrobial efficacy testing, microbiological research, and related laboratory environments.

Key Topics

• Production Method: The standard describes a step-by-step procedure to cultivate C. difficile spores from frozen stock cultures (including strains ATCC 700792, ATCC 43598, and ATCC 43599) using a commercially available liver broth medium under anaerobic conditions.
• Quality Criteria: Acceptable spore suspensions must meet the requirements of:
  • Titer exceeding 8 log₁₀ spores/mL
  • Minimum of 95% purity (spores vs. vegetative cells)
  • Resistance to 2.5M hydrochloric acid after a 10-minute exposure
• Equipment and Reagents: Detailed requirements for apparatus such as anaerobe jars, centrifuges, incubators, and microscopes. Essential reagents include liver broth, Butterfield’s phosphate buffer, sterile deionized water, and specific growth and recovery media.
• Safety and Laboratory Practices: The protocol is intended for use by trained personnel working within Biosafety Level 2 guidelines. It emphasizes adherence to Good Laboratory Practice (GLP) and user responsibility for safety, health, and environmental compliance.
• Calculations: Includes guidance on calculating percent spore purity and average colony-forming units (CFU) per milliliter, ensuring integrity and reproducibility across laboratories.
• Flexibility for Strain Use: Although the standard provides guidance for specific ATCC strains, it may also be applied to other C. difficile strains as required.

Applications

ASTM E3011-22 is widely applicable in microbiology, clinical research, public health, and pharmaceutical development:

• Antimicrobial and Disinfectant Testing: Generates standardized spore suspensions essential for evaluating the efficacy of antimicrobial agents, disinfectants, and sterilization protocols against C. difficile.
• Quality Control: Supports laboratories in producing reproducible and high-purity C. difficile spore stocks for comparative testing and internal validation.
• Research and Development: Serves microbiological studies focusing on the biology, pathogenesis, and control of C. difficile, or for studies requiring challenge organisms in efficacy testing.
• Regulatory Submissions: Provides standardized reference methods in support of submissions to regulatory agencies requiring validated laboratory practices and microbial challenge study data.

Related Standards

Adopting ASTM E3011-22 ensures compatibility and harmonization with other regulatory and testing processes. Related standards include:

• ASTM E2839: Practice for the production and storage of C. difficile spores for use in efficacy evaluation of antimicrobial agents.
• ASTM E2895: Practice for producing high titers of viable and semi-purified C. difficile spores using liquid media.
• ASTM E2756: Terminology relating to antimicrobial and antiviral agents for clear and consistent language.
• 40 CFR Part 160: Federal Good Laboratory Practice Standards, cited for laboratories conducting research on antimicrobial products.

Keywords: Clostridioides difficile, C. difficile spores, ASTM E3011-22, spore production, antimicrobial efficacy testing, liver broth, laboratory standard, microbiology, GLP, spore suspension.